SMAM
MDLN

Sugar Maple Asset Management’s Medline Inc MDLN Stock Holding History

Sugar Maple Asset Management’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,000
Closed -$267K – 91
2026
Q1 		$267K Buy
+6,000
New +$265K 0.16% 76

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sugar Maple Asset Management's MDLN Position: Q2 2026 in Review

Sugar Maple Asset Management sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 6,000 shares — an estimated $267K sold.

Sugar Maple Asset Management first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $267K in Q1 2026. 407 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Sugar Maple Asset Management reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
  • Sugar Maple Asset Management sold 6,000 Medline Inc shares in Q2 2026, an estimated $267K.
  • Sugar Maple Asset Management first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
  • Sugar Maple Asset Management's Medline Inc position peaked at $267K in Q1 2026.
  • 407 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Sugar Maple Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.